I see Merchant has just bought into arovella (ALA). The company has a dodgy history with two reboots, suspensions, plenty of raises and spending and nothing to show for it. Merchant now own 7.89% of a $20M market cap company. So about $1.5M worth. I can't tell from their website if they're taking a scattergun approach and hoping something hits by investing in all Aussie biotechs, or if they think ALA might finally be on to something.
I do not own any ALA, it will need a lot of homework first
MoF Newsletters, page-117
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
-0.020(1.19%) |
Mkt cap ! $282.8M | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.67 | $1.61 | $153.5K | 94.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.67 | 4080 | 1 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |